Rituximab Desensitization Therapy for Patients on the Waiting List for Kidney Transplant
Status:
Withdrawn
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
This is a study of patients who have a high risk of kidney rejection before kidney
transplant. The hypothesis is that treatment with a medication called rituximab will make it
possible for them to receive a kidney transplant from a donor who previously did not present
a good match.